The Association of Community Cancer Centers (ACCC) confers several Annual Awards to honor distinguished individuals who have made significant contributions to patient care, the practice of clinical care and research, and the greater oncology community.
The Annual Achievement Award recognizes individuals or an organization who have made outstanding contributions, nationally and/or internationally, to cancer care and to patients with cancer.
The 2020 award recipient is Lawrence N. Shulman, MD, MACP, FASCO, Professor of Medicine, Perelman School of Medicine, University of Pennsylvania; Deputy Director for Clinical Services, Abramson Cancer Center. Dr. Shulman is internationally known as a breast medical oncologist, oncology practice thought leader, and mentor. His breast cancer work in low-resourced areas throughout the United States and overseas have led to a significant improvement in patient outcomes in areas where women are at a greater risk.
The Clinical Research Award recognizes individuals whose research has significantly and positively impacted the oncology patient, family, and/or community.
The 2020 award recipient is Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology) & Professor of Pharmacology; Chief of Medical Oncology, Yale Cancer Center & Smilow Cancer Hospital; Associate Director for Translational Research, Yale Cancer Center; Interim Director, Yale Center for Immuno-oncology, Yale Cancer Center. Dr. Herbst has worked over several decades as a pioneer to identify biomarkers and bring novel targeted treatments and immunotherapies to patients, serving as principal investigator for numerous clinical trials testing these agents in advanced stage lung cancers.
The David King Community Clinical Scientist Award recognizes individuals who have demonstrated leadership in the development, participation, and evaluation of clinical studies and/or are active in the development of new screening, risk assessment, treatment, or supportive care programs for cancer patients.
The 2020 award recipient is Worta McCaskill-Stevens, MD, MS, Medical Oncologist, and Chief, Community Oncology and Prevention Trials Research Group. Dr. McCaskill-Stevens’ accomplishments are far-reaching and include a focus on cancer disparities; management of comorbidities within clinical trials; and molecular research to identify individuals who will benefit most from cancer prevention interventions. Her work in breast cancer research is notable.
Nominations and applications for the 2021 ACCC Annual Awards will open in March 2021. We encourage members to nominate their colleagues and peers in oncology.
In the wake of the COVID-19 pandemic, the demands on cancer programs and practices to be innovative in order to adapt and thrive are greater than ever. The 2021 ACCC Innovator Awards will recognize and support programs that have developed forward-thinking strategies to meet this new reality in cancer care delivery. The 2021 Call for Entries will open in early January 2021.
Questions? Please email Betsy Spruill, Member and Volunteer Engagement Manager, ACCC, or call 301.984.9496, ext. 206.
View the 2020 Innovator Award Winners
Roy S. Herbst, MD, PhD, Named ACCC 2020 Clinical Research Award Winner
Dec 14, 2020
Worta McCaskill-Stevens, MD, MS, Named 2020 ACCC David King Community Clinical Scientist Award Winner
Dec 14, 2020
Lawrence N. Shulman, MD, MACP, FASCO, Named ACCC 2020 Annual Achievement Award Winner
Dec 14, 2020